DE | EN | Русский | 中国语文 | | 日本語

corporate finance, m&a, berater, mergers, acquisitions, beratung

Overview Advisory Services

Life Sciences


Conalliance is one of the most active players in the life sciences in Mergers & Acquisitions advisory.

We work with a wide range of Life Sciences and Health Care companies to address the major challenges they face. Amplified business decisions are the new norm thanks to rapid changes.

The Life Sciences and Health Care industry group strives to support clients in addressing the challenges that impact today’s industry. From new market entrants and regulatory reform to expiring patents and the growing challenge of chronic diseases, leaders in the life sciences community must explore a new course to address the changing climate for health care — one driven by patients and focused on health outcomes.

Conalliance is regularly involved in large, industry-defining transactions, often across national borders. Our dedicated team completed prominent healthcare engagements, including healthcare services, pharmaceuticals, biotechnology and pharmalogistics. The global Conalliance network of relationships leverages our technical, industry and local expertise to create a unique platform for executing complex assignments.


Selected recent engagements include the following Life Sciences segments:


pfeil-gross Pharmaceuticals / drugs

pfeil-gross Pharmalogistics / Medical Distribution

pfeil-gross Diagnostics and Medical Laboratories

pfeil-gross Biotechnology

pfeil-gross Cosmoceuticals, Nutritional Supplement, Flavoring


ConAlliance provides companies and entrepreneurs with mergers & acquisitions and investment banking advisory services to the global Life Sciences Industries.



M&A Advisors for the Healthcare Industry



UK, London +44 (20) 81 44 36 00
USA, Chicago +1 (312) 38 00 85 0
China, Hong Kong +852 8197 90 20
Germany, Munich +49 (89) 809 53 63 0
Japan, Tokio + 81 50 553931-00